|Articles|May 20, 2021
Process Purification Development of Retrovirus-like Particle
Author(s)Bio-Rad Laboratories
Read a case study about resin screening, process development, and scale-up purification of a retrovirus-like particle which was scalable, fast, and low-cost during the clinical-grade manufacture of retrovirus vectors.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Challenges, Innovations, and Future Outlook of Biologics Formulations
2
A-TEEM: A Novel, Powerful Tool for Evaluating and Monitoring Cell Culture Media
3
CPHI Frankfurt 2025 Highlights Global Pharma Innovation and Manufacturing Leadership
4
Global Study Confirms Survival Advantage of Mogamulizumab in Advanced Mycosis Fungoides and Sézary Syndrome
5
